Drug Information

General Information
Drug ID
DR00081
Drug Name
Ergotidine
Synonyms
1H-Imidazole-4-ethanamine; 1H-Imidazole-5-ethanamine; 2-(1H-Imidazol-4-yl)ethanamine; 2-(1H-imidazol-4-yl)ethan-1-amine; 2-(1H-imidazol-5-yl)ethanamine; 2-(3H-Imidazol-4-yl)-ethylamine; 2-(4-Imidazolyl)ethylamine; 2-Imidazol-4-ylethylamine; 2-[4-Imidazolyl]ethylamine; 4-(2-Aminoethyl)-1H-imidazole; 4-Imidazoleethylamine; 5-Imidazoleethylamine; ALBB-005968; Beta-Aminoethylglyoxaline; Beta-Aminoethylimidazole; Beta-Imidazolyl-4-ethylamine; Beta-aminothethylglyoxaline; Eramin; Ergamine; F411C768-A159-4FC0-A195-291A08BB03AA; Free histamine; H7125_SIGMA; Histamine; Histamine (DCF); Histamine Base; Histamine [USAN]; Histamine, Free Base; Histaminum; Histaminum (TN); Imidazole-4-ethylamine; Istamina; Istamina [Italian]; L-histamine; Theramine; ZERO/004089; [3H]histamine
Drug Type
Small molecular drug
Indication Migraine [ICD11: 8A80] Approved [1]
Therapeutic Class
Antiallergic Agents
Structure
3D MOL 2D MOL
Formula
C5H9N3
Canonical SMILES
C1=C(NC=N1)CCN
InChI
InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)
InChIKey
NTYJJOPFIAHURM-UHFFFAOYSA-N
CAS Number
CAS 75614-87-8
Pharmaceutical Properties Molecular Weight 111.15 Topological Polar Surface Area 54.7
Heavy Atom Count 8 Rotatable Bond Count 2
Hydrogen Bond Donor Count 2 Hydrogen Bond Acceptor Count 2
XLogP
-0.7
PubChem CID
774
PubChem SID
10524836 , 11108702 , 11111275 , 11120367 , 11120855 , 11121343 , 11121734 , 11122214 , 11335483 , 11360722 , 11362871 , 11363739 , 11365433 , 11366301 , 11367995 , 11368863 , 11370953 , 11370954 , 11371444 , 11373596 , 11374718 , 11376157 , 11377025 , 11461694 , 11484465 , 11488481 , 11490268 , 11492775 , 11494659 , 11537616 , 15146444 , 16080673 , 3156918 , 3221723 , 3678 , 3727072 , 5065169 , 5186157 , 609692 , 6436474 , 7735853 , 7888228 , 7979989 , 8139979 , 8143824 , 8150782 , 822767 , 824161 , 853773 , 91789
ChEBI ID
ChEBI:18295
TTD Drug ID
D04USC
DT(s) Transporting This Drug ENT4 Transporter Info Equilibrative nucleoside transporter 4 Substrate [2]
OCT-2 Transporter Info Organic cation transporter 2 Substrate [3]
OCT-3 Transporter Info Organic cation transporter 3 Substrate [4]
VMAT1 Transporter Info Vesicular amine transporter 1 Substrate [5]
VMAT2 Transporter Info Vesicular amine transporter 2 Substrate [6]
Drug-Transporter Activity Data
Drug-Transporter Activity Data OCT-2 Transporter Info Km = 940 microM Human embryonic kidney cells (HEK293)-OCT2 [4]
OCT-2 Transporter Info Km = 1300 microM Oocytes-OCT2 [7]
OCT-3 Transporter Info Km = 180 microM Human embryonic kidney cells (HEK293)-OCT3 [8]
OCT-3 Transporter Info Km = 220 microM Human embryonic kidney cells (HEK293)-OCT3 [4]
References
1 Ergotidine was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Histamine uptake mediated by plasma membrane monoamine transporter and organic cation transporters in rat mast cell lines. Eur J Pharmacol. 2019 Apr 15;849:75-83.
3 The organic cation transporters (OCT1, OCT2, EMT) and the plasma membrane monoamine transporter (PMAT) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua. Mol Reprod Dev. 2007 Oct;74(10):1303-11.
4 Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006 Jun;50(8):941-52.
5 Gastrin-producing endocrine cells: a novel source of histamine in the rat stomach. Endocrinology. 1998 Oct;139(10):4404-15.
6 The vesicular monoamine transporter 2: an underexplored pharmacological target. Neurochem Int. 2014 Jul;73:89-97.
7 Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine. Mol Pharmacol. 1998 Aug;54(2):342-52.
8 Selective substrates for non-neuronal monoamine transporters. Mol Pharmacol. 1999 Jul;56(1):1-10.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.